Background: Persistent lymphadenopathy poses a diagnostic challenge: the differential diagnosis ranges from benign processes to life-threatening conditions, and initial investigations are frequently negative.
Case Presentation: We report a previously healthy 21-month-old Brazilian boy, who presented to the Emergency Department with painless bilateral submandibular masses of two days’ duration, the right one with stone-like consistency. He was vaccinated according to the Brazilian program, including BCG, and had recently moved to Portugal. No contact with animals or with unpasteurized milk was reported. Cervical ultrasound revealed suppurated bilateral lymphadenopathy, and he was discharged with oral amoxicillin and clavulanic acid for presumed suppurative adenitis. Eighteen days after symptom onset, he was re-admitted for new inflammatory signs over the left cervical mass. No associated B symptoms. Laboratory tests showed only mild C-reactive protein elevation. Ultrasound revealed a poorly defined left-sided fluid collection, which was surgically drained. Intravenous ceftriaxone and clindamycin were initiated for adenitis complicated by adenophlegmon, without improvement. Extensive microbiological and serological investigation was negative, including HIV screening, blood and pus bacterial cultures, and molecular blood testing for bacteria (including Bartonella spp.), viruses and fungi, as well as for Mycobacterium tuberculosis and M. avium. Fine-needle aspiration excluded malignancy, showed no granulomas and a negative Ziehl–Neelsen staining. Underlying immune defects were excluded. A positive IGRA prompted tuberculosis investigation, with normal chest imaging and negative gastric aspirates and stool samples. Despite these negative results, antituberculous therapy (HRZE) was started on clinical suspicion. Molecular biology analysis of the drained pus was positive for Mycobacterium tuberculosis complex (MTBc), later confirmed by mycobacterial culture growth. The patient improved steadily within the first month and completed two months of induction therapy with HRZE. Meanwhile, pyrazinamide resistance detection on the MTBc phenotypical antimicrobial susceptibility testing prompted further MTBC species identification. The isolate was then identified as a non-vaccinal strain of Mycobacterium bovis, using GenoType Mycobacterium MTBc kit. The patient completed four months of maintenance treatment with HRE, with favorable response. Family tuberculosis screening was negative, and no other relevant epidemiological exposure was identified.
Learning Points: Persistent lymphadenopathy with negative first-line investigations should raise early suspicion of mycobacterial disease; empirical antituberculous therapy should not be withheld while awaiting culture confirmation. Molecular testing of drained material should always be performed, as it may provide a faster response.
BCG vaccination does not exclude Mycobacterium bovis infection: non-vaccinal strains can cause disease, and their intrinsic pyrazinamide resistance requires the standard regimen to be adapted. While rare in developed countries – due to bovine tuberculosis control and routine milk pasteurisation – M. bovis should be considered in children with a migration history, even when no exposure is identified.

